Ominimo — Funding & Company Data

Ominimo's funding trajectory is atypical and signals strong early performance. The company was reportedly profitable within its first year of operation in Hungary before taking any external capital. The April 2025 Series A round of €10 million (approx. $11.6M) was not just a capital injection but a strategic partnership with Zurich Insurance Group, one of the world's largest insurers. Zurich acquired a minority stake, reportedly 5%, at a substantial €200 million (approx. $232M) valuation, which is exceptionally high for a one-year-old company in its first funding round.

This move suggests high confidence from an established industry leader in Ominimo's proprietary AI-driven underwriting technology and its ability to scale efficiently. The company claims its data models use hundreds of variables, far exceeding the industry standard, to price risk more accurately and offer lower premiums. The partnership provides Ominimo with the balance sheet and credibility of Zurich, which will act as the risk carrier in new markets, while Ominimo operates as a managing general agent (MGA), focusing on technology and customer experience.

Investor quality is top-tier for the insurtech space. Securing a strategic investment from a global insurance giant like Zurich provides more than just capital; it offers a clear distribution channel, regulatory know-how, and a powerful endorsement. This significantly de-risks the company's expansion plans, which include entering over 10 new European markets starting with Poland, Sweden, and the Netherlands. From a competitive standpoint, this backing gives Ominimo a formidable advantage over other insurtech startups that may struggle for capital and legitimacy. The company's disciplined, profit-focused approach from its inception, coupled with this strategic funding, suggests a sustainable path to growth, unlike many cash-burning startups.